Scar Clinical Trial
— SCAROfficial title:
Assessment of Cutaneous Leishmaniasis Scar (Caused by Leishmania Major) for Cosmetic Outcome After Treatment With WR279396 (Paromomycin/Gentamicin Cream in Vehicle) Versus a No Treatment Control Group (Natural Healing)
Primary Objectives:
Assess whether CL (caused by Leishmaniasis major) lesions treated with WR279396 improved the
cosmetic outcome compared with no treatment (natural healing)
Status | Completed |
Enrollment | 108 |
Est. completion date | June 2007 |
Est. primary completion date | June 2007 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 5 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Included are volunteers who participated in WRAIR 813 (HSRRB Log # 9768.1) and those who participated in another CL study in/around the WRAIR 813 study site who had been assigned to a "no-treatment" (natural healing) arm. All volunteers will have had documented CL in the past that were treated with WR279396, vehicle, or no treatment (natural history), have signed informed consent, and are willing to comply with study assessments; age range: 5 to 75 years old. - For study subjects who were enrolled in WRAIR 813 in 2004 (WR279396 or vehicle treated): - Written informed consent obtained from the subject or guardian - Willing to meet the requirements of the single clinic visit - Prior data in the clinical site data base documenting a diagnosis of CL - Each lesion for inclusion in this study conforms to WRAIR 813: ³ 1 cm in diameter and was primarily ulcerative (i.e., not verrucous or nodular) - The index lesion and others to be scored were proven parasitologically by Giemsa slide smear - CL scars documented to be > 360 days old (clock starts at time of diagnosis) - No treatment of the lesions other than that received in the previous protocol - Study subjects from the earlier studies to serve as "no treatment" controls: - Written informed consent obtained from the subject or guardian - Willing to meet the requirements of the single clinic visit - Same age range as WRAIR 813: 5-75 years old at time of diagnosis - Prior data in the clinical site data base documenting a diagnosis of CL, and that the volunteer was assigned to the "no treatment" group - Each lesion for inclusion in this study will conform to WRAIR 813: at the time of diagnosis, =1 cm in diameter and described as primarily ulcerative (i.e., not verrucous or nodular) - At least 1 lesion that was proven parasitologically by Giemsa slide smear for inclusion in the earlier study. - CL scars documented to be > 360 days old (clock starts at time of diagnosis) - Never received any treatment of the lesions (natural healing) or applied any medication, such as herbal medication - Lesions present on the trunk or extremities, to match the WRAIR 813 study volunteers (no facial lesions were treated in the 2004 study) Exclusion Criteria: - Potential volunteers without a prior documented diagnosis of CL |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Tunisia | Institute Pasteur de Tunis | Tunis |
Lead Sponsor | Collaborator |
---|---|
U.S. Army Medical Research and Materiel Command | Institut Pasteur |
Tunisia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cosmetic outcome based on modified Vancouver Scar Score (mVSS) | The primary cosmetic outcome measure is the Clinical Scar Rating, based on a modified Vancouver Scar Score (mVSS). The primary efficacy endpoint is the percent of persons judged to have either a "superior (no scar)" or "excellent" rating (see below). | Day 360 or greater | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Completed |
NCT01706848 -
Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a Wound
|
N/A | |
Recruiting |
NCT01177358 -
Botox in the Healing of Surgical Wounds of the Neck
|
Phase 2 | |
Terminated |
NCT01459666 -
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
|
Phase 4 | |
Completed |
NCT00970671 -
Treatment of Surgical Scars Using the Pulsed Dye Laser
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Completed |
NCT05293652 -
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
|
N/A | |
Recruiting |
NCT03406143 -
Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration
|
N/A | |
Completed |
NCT05527756 -
Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery
|
||
Completed |
NCT02886988 -
Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection
|
Phase 2/Phase 3 | |
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
Recruiting |
NCT05408117 -
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
|
N/A | |
Completed |
NCT04169438 -
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
|
N/A | |
Terminated |
NCT02520557 -
An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate
|
||
Not yet recruiting |
NCT04621994 -
Cesarean Wound Closure: Dermabond Versus Steri Strips
|
N/A | |
Withdrawn |
NCT03395678 -
Acne Scarring in Skin of Color: Laser vs Microneedling
|
N/A | |
Completed |
NCT02744950 -
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
|
N/A | |
Not yet recruiting |
NCT01005992 -
Fractional Photothermolysis for the Treatment of Burn Scars
|
Phase 1 | |
Completed |
NCT04870008 -
Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm)
|
N/A | |
Recruiting |
NCT04506255 -
Silicone Taping for the Improvement of Abdominal Donor Site Scars
|
N/A |